Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 2
2002 2
2003 1
2004 1
2005 4
2006 3
2009 2
2010 2
2012 2
2014 3
2015 2
2016 3
2017 5
2018 3
2019 4
2020 6
2021 12
2022 8
2023 5
2024 8
2025 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
Dynamics and durability of HIV-1 neutralization are determined by viral replication.
Schommers P, Kim DS, Schlotz M, Kreer C, Eggeling R, Hake A, Stecher M, Park J, Radford CE, Dingens AS, Ercanoglu MS, Gruell H, Odidika S, Dahlhaus M, Gieselmann L, Ahmadov E, Lawong RY, Heger E, Knops E, Wyen C, Kümmerle T, Römer K, Scholten S, Wolf T, Stephan C, Suárez I, Raju N, Adhikari A, Esser S, Streeck H, Duerr R, Nanfack AJ, Zolla-Pazner S, Geldmacher C, Geisenberger O, Kroidl A, William W, Maganga L, Ntinginya NE, Georgiev IS, Vehreschild JJ, Hoelscher M, Fätkenheuer G, Lavinder JJ, Bloom JD, Seaman MS, Lehmann C, Pfeifer N, Georgiou G, Klein F. Schommers P, et al. Among authors: kroidl a. Nat Med. 2023 Nov;29(11):2763-2774. doi: 10.1038/s41591-023-02582-3. Epub 2023 Nov 13. Nat Med. 2023. PMID: 37957379 Free PMC article.
Profiling of HIV-1 elite neutralizer cohort reveals a CD4bs bnAb for HIV-1 prevention and therapy.
Gieselmann L, DeLaitsch AT, Rohde M, Gruell H, Kreer C, Ercanoglu MS, Gristick HB, Schommers P, Ahmadov E, Radford C, Mazzolini A, Zhang L, West AP Jr, Worczinski J, Momot A, Reichwein ML, Knüfer J, Stumpf R, Mkhize NN, Kaldine H, Bhebhe S, Deshpande S, Giovannoni F, Stefanutti E, Benigni F, Havenar-Daughton C, Corti D, Kroidl A, Adhikari A, Nanfack AJ, Ambada GE, Duerr R, Maganga L, William W, Ntinginya NE, Wolf T, Geldmacher C, Hoelscher M, Lehmann C, Moore PL, Mora T, Walczak AM, Gilbert PB, Doria-Rose NA, Huang Y, Bloom JD, Seaman MS, Bjorkman PJ, Klein F. Gieselmann L, et al. Among authors: kroidl a. Nat Immunol. 2025 Nov;26(11):2016-2029. doi: 10.1038/s41590-025-02286-5. Epub 2025 Oct 6. Nat Immunol. 2025. PMID: 41053396 Free PMC article.
Identification of a broad and potent V3 glycan site bNAb targeting an N332gp120 glycan-independent epitope.
Gieselmann L, DeLaitsch AT, Rohde M, Radford C, Worczinski J, Momot A, Ahmadov E, Burger JA, Havenar-Daughton C, Deshpande S, Giovannoni F, Corti D, Kreer C, Ercanoglu MS, Schommers P, Georgiev IS, West AP Jr, Knüfer J, Stumpf R, Kroidl A, Geldmacher C, Maganga L, William W, Ntinginya NE, Hoelscher M, Yang Z, Wei Q, Renfrow M, Green TJ, Novak J, van Gils MJ, Gristick HB, Gruell H, Bloom JD, Seaman MS, Bjorkman PJ, Klein F. Gieselmann L, et al. Among authors: kroidl a. bioRxiv [Preprint]. 2025 Sep 10:2025.09.05.674437. doi: 10.1101/2025.09.05.674437. bioRxiv. 2025. PMID: 40964353 Free PMC article. Preprint.
HPV Type Distribution in HIV Positive and Negative Women With or Without Cervical Dysplasia or Cancer in East Africa.
Mcharo R, Lennemann T, France J, Torres L, Garí M, Mbuya W, Mwalongo W, Mahenge A, Bauer A, Mnkai J, Glasmeyer L, Judick M, Paul M, Schroeder N, Msomba B, Sembo M, Chiwerengo N, Hoelscher M, Geisenberger O, Lelle RJ, Saathoff E, Maboko L, Chachage M, Kroidl A, Geldmacher C. Mcharo R, et al. Among authors: kroidl a. Front Oncol. 2021 Nov 30;11:763717. doi: 10.3389/fonc.2021.763717. eCollection 2021. Front Oncol. 2021. PMID: 34917506 Free PMC article.
Profiling a large HIV-1 elite neutralizer cohort reveals remarkable CD4bs bNAb for HIV-1 prevention and therapy.
Gieselmann L, DeLaitsch AT, Rohde M, Gruell H, Kreer C, Ercanoglu MS, Gristick HB, Schommers P, Ahmadov E, Radford C, Mazzolini A, Zhang L, West AP Jr, Worczinski J, Momot A, Reichwein ML, Knüfer J, Stumpf R, Mkhize NN, Kaldine H, Bhebhe S, Deshpande S, Giovannoni F, Stefanutti E, Benigni F, Havenar-Daughton C, Corti D, Kroidl A, Adhikari A, Nanfack AJ, Ambada GE, Duerr R, Maganga L, William W, Ntinginya NE, Wolf T, Geldmacher C, Hoelscher M, Lehmann C, Moore PL, Mora T, Walczak AM, Gilbert PB, Doria-Rose NA, Huang Y, Bloom JD, Seaman MS, Bjorkman PJ, Klein F. Gieselmann L, et al. Among authors: kroidl a. bioRxiv [Preprint]. 2025 Aug 27:2025.08.27.672638. doi: 10.1101/2025.08.27.672638. bioRxiv. 2025. Update in: Nat Immunol. 2025 Nov;26(11):2016-2029. doi: 10.1038/s41590-025-02286-5. PMID: 40909752 Free PMC article. Updated. Preprint.
A two-drug regimen for antiretroviral therapy.
Kroidl A, Eberle J. Kroidl A, et al. Lancet. 2019 Jan 12;393(10167):106-108. doi: 10.1016/S0140-6736(18)32783-1. Epub 2018 Nov 9. Lancet. 2019. PMID: 30420122 No abstract available.
A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).
Kibuuka H, Kimutai R, Maboko L, Sawe F, Schunk MS, Kroidl A, Shaffer D, Eller LA, Kibaya R, Eller MA, Schindler KB, Schuetz A, Millard M, Kroll J, Dally L, Hoelscher M, Bailer R, Cox JH, Marovich M, Birx DL, Graham BS, Michael NL, de Souza MS, Robb ML. Kibuuka H, et al. Among authors: kroidl a. J Infect Dis. 2010 Feb 15;201(4):600-7. doi: 10.1086/650299. J Infect Dis. 2010. PMID: 20078213 Free PMC article. Clinical Trial.
82 results